fbpx
  • Home
  • Study Details
Not currently enrolling

VOR-07 Study

"This study is looking at combining 2 medications to evaluate the ability of the combination to decrease the size of the latent reservoir. We will test the use of an antibody called VRC07-523LS to stimulate the immune system to fight HIV infection. We will give the drug Vorinostat (VOR) to stimulate the release of HIV from the latent reservoir. Previous research studies show that VOR has the ability to stimulate some non-active HIV infected cells to become active and release HIV virus. The purpose of this study is to: • Evaluate the safety of VOR in combination with VRC07-523LS • Evaluate the safety of two series of a VRC07-523LS infusion followed by multiple oral doses of VOR • Determine if combining VRC07-523LS and VOR can have an impact on the size of the latent reservoir."

Age & Gender

  • 18 years ~ 64 years
  • Male, Female

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Cindy Gay
Medicine-Infectious Diseases

Study Topics

HIV/AIDS

IRB Number

18-1217

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.